Three‐dimensional neuromelanin‐sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease
European Journal of Neurology2018Vol. 25(4), pp. 680–686
Citations Over TimeTop 10% of 2018 papers
Shweta Prasad, Albert Stezin, Abhishek Lenka, Lija George, Jitender Saini, Ravi Yadav, Pramod Kumar Pal
Abstract
Contrast ratio analysis of the SNc using 3D neuromelanin-sensitive MRI may serve as a quick and accurate tool to discern between patients with PD and healthy controls.
Related Papers
- → Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease(2006)499 cited
- → Detecting parkinsonian degeneration in lateroventral tier of substantia nigra pars compacta with MRI(2020)2 cited
- → Synchrotron radiation based X-ray fluorescence shows changes in the elemental composition of the human substantia nigra in aged brains(2015)18 cited
- → Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson's disease that we were looking for?(2018)4 cited
- → Isolation of Neuromelanin Granules(2008)3 cited